Daniel Engelbertsen
21 – 30 of 31
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Dendritic cell KLF2 expression regulates T cell activation and proatherogenic immune responses
(
- Contribution to journal › Article
-
Mark
Blockade of Tim-1 and Tim-4 enhances atherosclerosis in low-density lipoprotein receptor-deficient mice
(
- Contribution to journal › Article
- 2015
-
Mark
Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Low Levels of IgM Antibodies against an Advanced Glycation Endproduct-Modified Apolipoprotein B100 Peptide Predict Cardiovascular Events in Nondiabetic Subjects.
(
- Contribution to journal › Article
-
Mark
Expansion of CD25+ Innate Lymphoid Cells Reduces Atherosclerosis
(
- Contribution to journal › Article
- 2014
-
Mark
Induction of T helper 2 responses against human Apolipoprotein B100 does not affect atherosclerosis in ApoE-/- mice.
2014) In Cardiovascular Research(
- Contribution to journal › Article
- 2013
-
Mark
Adaptive Immunity in Cardiovascular Disease
(
- Thesis › Doctoral thesis (compilation)
-
Mark
T-Helper 2 Immunity Is Associated With Reduced Risk of Myocardial Infarction and Stroke.
2013) In Arteriosclerosis, Thrombosis and Vascular Biology(
- Contribution to journal › Article
- 2012
-
Mark
High levels of IgM against methylglyoxal-modified apolipoprotein B100 is associated with less coronary artery calcification in patients with type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Increased Inflammation in Atherosclerotic Lesions of Diabetic Akita-LDLr(-/-) Mice Compared to Nondiabetic LDLr(-/-) Mice.
(
- Contribution to journal › Article